Table 1 Clinicopathological of breast patients with clustered microcalcifications

Age, years (range)

52.07 ± 8.32 (36–76)

Breast lesions (%)

 Left

39 (54.93%)

 Right

32 (45.07%)

Calcification location (%)

 Upper outer quadrant

28 (39.44%)

 Upper inner quadrant

12 (16.90%)

 Lower inner quadrant

14 (19.72%)

 Lower outer quadrant

1 (1.41%)

 Inner quadrant

2 (2.82%)

 Outer quadrant

2 (2.82%)

 Upper quadrant

4 (5.63%)

 Central area

6 (8.45%)

 Unknown

2 (2.82%)

MG BI-RADS (%)

 4 A

23 (32.39%)

 4B

26 (36.62%)

 4 C

13 (18.31%)

 5

9 (12.68%)

Size of microcalcification area, CC view, mm^ab (range)

11.22 ± 7.95 (2.41–42.89)

Size of microcalcification area, MLO view, mm^b (range)

11.75 ± 7.79 (2.48–39.51)

Max diameter of microcalcified nodule, CC view, mm^ab (range)

1.13 ± 1.13 (0.22–7.55)

Max diameter of microcalcified nodule, MLO view, mm^b (range)

1.15 ± 1.06 (0.30–7.36)

Average gray value of calcified area, MLO^b (range)

2,552.02 ± 221.32 (1,911.92–3,178.62)

Average gray value of paraglandular, MLO^b (range)

2,472.02 ± 218.40 (1,854.66–3,137.37)

Gray ratio, calcified area /paraglandular, MLO^b (range)

1.03 ± 0.22 (0.98–1.09)

Gray difference, calcified area - paraglandular, MLO^b (range)

80.00 ± 52.95 (-42.05–237.97)

CT localization

 Yes (%)

42 (59.15%)

 Size of calcification, coronal view, mm^b (range)

10.37 ± 7.89 (1.48–32.58)

 Size of calcification, sagittal view, mm^b (range)

7.49 ± 8.26 (1.00–41.25)

 No (%)

29 (40.85%)

Surgical type (%)

 Wide excision

29 (40.85%)

 Breast conserving surgery

6 (8.45%)

 Mastectomy ± reconstruction

36 (50.70%)

Tumor size, cm^b (range)

1.49 ± 1.09 (0.30–4.50)

 Benign

1.14 ± 0.54 (0.50–2.00)

 Atypical hyperplasia

0.70 ± 0.54 (0.10–1.50)

 Cancer

1.74 ± 1.22 (0.40–4.50)

Pathology (%)

 Benign

23 (32.39%)

 Atypical hyperplasia

6 (8.45%)

 Cancer

42 (59.15%)